COVID-19 treatment

December 10, 2020

Vanderbilt LifeFlight sees large increase in Covid-19 transports

Vanderbilt LifeFlight has transported more than 220 Covid-19 patients since the pandemic started with the numbers rising dramatically in the last few weeks.

By Jerry Jones
James Crowe Jr., MD, and colleagues are exploring how the body’s immune system gears up to fight off infection.
December 1, 2020

Vanderbilt University Medical Center’s Crowe receives 2020 “Golden Goose” Award for COVID-19 research

James Crowe Jr., MD, a physician-scientist at Vanderbilt University Medical Center who has pioneered development of human monoclonal antibodies as potential treatments for viral diseases, has won a 2020 “Golden Goose” Award.

By Bill Snyder
November 30, 2020

Rounds: Pouring a cup of ambition as the journey wears on

In the midst of a long, hard trek, we are inclined to focus on the miles remaining — forgetting all the terrain we’ve already conquered. Taking a few moments to reflect on where we started and how far we’ve come can replenish resilience, restoring vital energy to keep moving.

By VUMC News and Communications
November 23, 2020

Is it true that work on a COVID-19 vaccine at Vanderbilt University Medical Center was funded by Dolly Parton?

Funds from her gift have supported important advancements in VUMC’s war on COVID
November 23, 2020

NCI director urges action to address delayed cancer diagnoses

Delayed cancer diagnoses and treatment due to concerns about potential coronavirus exposure will lead to collateral deaths beyond the pandemic, National Cancer Institute (NCI) Director Ned Sharpless, MD, said Thursday during a virtual visit at Vanderbilt University Medical Center.

By Tom Wilemon
November 18, 2020

Why does COVID-19 seem to spare children? Vanderbilt University Medical Center study offers an answer 

Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. 

By Bill Snyder
November 9, 2020

Hydroxychloroquine does not help patients hospitalized with COVID-19: Study

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.
By Bill Snyder
November 6, 2020

Elevate Team Award celebrates COVIDRX team’s coordinated, statewide distribution of COVID-19 therapeutic

"The team focused on the patients. We took a Vanderbilt Credo and extended it and portrayed it for the entire state of Tennessee.”
By Bill Snyder
November 2, 2020

VUMC begins study of second COVID-19 vaccine

Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.
By Bill Snyder
October 29, 2020

VUMC’s resilience amid COVID: Caring for ourselves as we care for others

Caring for ourselves and for one another will be fundamental to the people of Vanderbilt University Medical Center in the coming weeks as COVID-19 is surging, and over the year as the enterprise adapts further to changes while expanding locally and regionally.
By Holly Fletcher
October 29, 2020

Rini to lead NCI study of COVID-19 in cancer patients

Brian Rini, MD, is leading a study launched by the National Cancer Institute (NCI) that will closely monitor cancer patients who acquire COVID-19 with the goal of providing highly detailed data to guide future care.
By Tom Wilemon
October 26, 2020

National Academy of Medicine addresses urgent threats of COVID-19 and climate change at annual meeting

The COVID-19 pandemic and climate change are twin calamities that cannot be resolved without global cooperation, consistent communication and leadership and urgent innovation by the scientific community.
By Bill Snyder
October 26, 2020

COVID treatment studied by VUMC gains FDA approval

Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19.
By Bill Snyder
1 … 5 6 7 8 9 … 12